We are pleased to announce that Stability Health has now raised a total of $10 million in seed funding. A final close of $7.5 million second-round funding was held July 29, 2022.
Stability Health will use this latest investment to expand upon its strength of bringing clinical expertise, technology and humanity into the delivery of diabetes care, facilitating greater outcomes on a national level.
According to Nick Loporcaro, the former CEO of Landmark Health and an investor in this financing, it’s the senior leadership team and technology platform that sets Stability Health apart. He said, “What attracted me is how the team has incorporated their deep knowledge of diabetes and successful clinical experience into a technology platform that solves the challenges of complex diabetes.”